Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Cambrex to Announce Third Quarter 2017 Financial Results on November 7, 2017

Posted on: 31 Oct 17

EAST RUTHERFORD, N.J., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that third quarter 2017 financial results will be released on Tuesday, November 7, 2017 before the market opens.

The Company will host a conference call to discuss the financial results.

 Third Quarter 2017 Earnings Conference Call
When:Tuesday, November 7, 2017 at 8:30 a.m. Eastern Time
Dial-in:1-866-548-4713 for U.S.
 1-323-794-2093 for International
 Passcode:  1511082
Dial-in Replay:1-888-203-1112 for U.S.
 1-719-457-0820 for International
 Passcode:  1511082
 Available through Tuesday, November 14, 2017 

About Cambrex 
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances.  For more information, please visit

Stephanie LaFiura
Investor Relations Associate
Tel: 201-804-3037



Last updated on: 01/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.